Joanne McCaigue

Phase 1/2 Study of the Safety and Response of P-BCMA-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME) with Novel Therapeutic Strategies

Caitlin Costello, Adam D. Cohen, Krina K. Patel et al. · Blood · 2020 · 76 citations

Medicine, Hematology, Immunology +15

Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC).

Susan F. Slovin, Tanya B. Dorff, Gerald S. Falchook et al. · Journal of Clinical Oncology · 2022 · 51 citations

Medicine, Oncology, Pharmacology +17

Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System

Caitlin Costello, Ben A Derman, Mehmet H. Kocoglu et al. · Blood · 2021 · 25 citations

Life Sciences, Immunology, Oncology +16

Early Safety Results of P-BCMA-ALLO1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (CAR-T), in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

Bhagirathbhai Dholaria, Mehmet H. Kocoglu, Andrew Kin et al. · Blood · 2023 · 24 citations

Life Sciences, Hematology, Immunology +12

728 Phase 1 study of P-MUC1C-ALLO1 allogeneic CAR-T cells in patients with epithelial-derived cancers

Jason T. Henry, David Oh, Jeff Eskew et al. · Regular and Young Investigator Award Abstracts · 2022 · 14 citations · Full text

Medicine, Immunology, Oncology +14